Skip to content

Application Research of Digital Chest Drainage System in Residual Cavity Elimination and Complication Management After Pulmonary Resection in Thoracic Surgery Patients

Application Research of Digital Chest Drainage System in Residual Cavity Elimination and Complication Management After Pulmonary Resection in Thoracic Surgery Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111269
Enrollment
Unknown
Registered
2025-10-29
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Diseases

Interventions

Control Group:Traditional Closed Thoracic Drainage
Experimental Group:Digital Chest Drainage

Sponsors

Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Type of surgery: Elective lobectomy, segmentectomy. 2. Age range: =18 years old, no gender restrictions. 3. Functional status: Karnofsky Performance Status (KPS) =70 points. 4. Postoperative Drainage Requirement: A chest drainage tube must be retained postoperatively, with an anticipated drainage duration of =24 hours. 5. Informed Consent: Patients voluntarily participate in the study, sign a written informed consent form, and commit to completing a 3-month postoperative follow-up.

Exclusion criteria

Exclusion criteria: 1. Severe comorbidities: Uncontrolled heart failure, severe chronic obstructive pulmonary disease (COPD), immunosuppressed status, etc. 2. Perioperative high-risk factors: Prolonged preoperative anticoagulant/antiplatelet therapy with inability to safely discontinue postoperatively; intraoperative discovery of extensive pleural adhesions, etc. 3. Postoperative special conditions: Requiring transfer to the intensive care unit (ICU) for mechanical ventilation support; occurrence of bronchopleural fistula or active haemorrhage during surgery; 4. Other circumstances deemed unsuitable for participation in this study by the investigator.

Design outcomes

Primary

MeasureTime frame
Postoperative Incidence of Intrathoracic Residual Cavity;Postoperative Incidence of Complications;

Secondary

MeasureTime frame
Respiratory Function Indicators;Adverse Event;Quality of Life Score;Postoperative Pain Score;

Countries

China

Contacts

Public ContactAo Yu

Drum Tower Hospital

yuaosc@163.com+86 25 8310 6666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026